SCHEMBL8712586

SCHEMBL8712586

CCN1c2ccccc2Sc2cc(CCl)ccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 4/20 0.46
HDAC3 O15379 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
PTGS1 P23219 3/20 0.43
PTGS2 P35354 2/20 0.43
ALDH1A1 P00352 5/20 0.43
HPGD P15428 3/20 0.43
MAPT P10636 2/20 0.43
HTT P42858 2/20 0.43
CYP2D6 P10635 5/20 0.42
ADRA2A P08913 4/20 0.42
SLC6A2 P23975 4/20 0.42
SLC6A4 P31645 4/20 0.42
DRD3 P35462 4/20 0.42
ALOX15 P16050 3/20 0.42
HSD17B10 Q99714 3/20 0.42
SLC22A1 O15245 3/20 0.42
CYP1A2 P05177 3/20 0.42
CHRM2 P08172 3/20 0.42
HTR1A P08908 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13067104 0.88 CYP2D6 (0.53) KDM1APTGS1PTGS2ALDH1A1HPGD
SCHEMBL8715308 0.85 PTGS1 (0.46) KDM1AHDAC3HDAC6PTGS1PTGS2
SCHEMBL8711778 0.84 MAOA (0.61) KDM1AALDH1A1HPGDMAPTCYP2D6
SCHEMBL293951 0.82 KDM1A (0.61) KDM1APTGS1PTGS2ALDH1A1HPGD
SCHEMBL29557425 0.82 KDM1A (0.61) KDM1APTGS1PTGS2ALDH1A1HPGD
SCHEMBL628426 0.81 ITGB2 (0.56) KDM1AALDH1A1HPGDMAPTHTT
SCHEMBL23265178 0.81 KDM1A (0.43) KDM1APTGS1PTGS2ALDH1A1HPGD
SCHEMBL628451 0.80 KDM1A (0.49) KDM1APTGS1PTGS2ALDH1A1HPGD
SCHEMBL8905978 0.79 CYP2D6 (0.43) KDM1APTGS1PTGS2ALDH1A1HPGD
SCHEMBL627961 0.78 KDM1A (0.48) KDM1APTGS1PTGS2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5830902-A SQUALENE SYNTHASE INHIBITOR YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1998-11-03 US disclosed
CN-1177353-A Novel quinuclidine derivatives having tricyclic fused hereto ring YAMANOUCHI PHARMA CO LTD (JP) 1998-03-25 CN disclosed
EP-0812840-A1 NOVEL QUINUCLIDINE DERIVATIVES HAVING TRICYCLIC FUSED HETERO RING YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1997-12-17 EP disclosed